Risk factors for linezolid - induced haematological toxicity in patients: a retrospective study
Renal insufficiency is a related risk factor for linezolid-induced hematological toxicity. Patients receiving linezolid treatment should be closely monitored with blood routine and plasma concentration, particularly in patients with moderate or severe renal insufficiency. The plasma trough concentration of linezolid could be a suitable predictor for linezolid-induced thrombocytopenia and anemia.
Authors
- YingE Liang
- Kai Mo (ORCID: https://orcid.org/0000-0003-1738-746X)
- YanE Qin
- JuMan Li
- RuHua Wei
- YaTing Lu
- Wen Cao (ORCID: https://orcid.org/0009-0009-1225-8678)
- Hui Zhong
- MingWei Meng
- XiaoBu Lan
Institutions
- First Affiliated Hospital of GuangXi Medical University (CN)
- Riverside Hospital of Guangxi Zhuang Autonomous Region (CN)
- First People's Hospital of Nanning (CN)
Publication Details
- Journal
- The Journal of Infection in Developing Countries
- Published
- 2024-08-31
- DOI
- https://doi.org/10.3855/jidc.18366
- Citations
- 3
- Primary Topic
- Antimicrobial Resistance in Staphylococcus
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- Bethune Charitable Foundation